A team at The Institute of Cancer Research (ICR), London and the Clinical Trials Research Unit (CTRU) at the University of Leeds adopted a new high-speed trial methodology.
News
NHS waiting times reach record high of nearly six million
In October 2021, over 356,000 people in England had been waiting for over six weeks for a key diagnostic test
Health minister welcomes new treatments for COVID-19 patients
The treatments are being offered as an addition to vaccinations to maximise protection against COVID-19
NICE publish final guidance recommending Aspaveli in adults with ultra-rare blood disorder
The drug is additionally undergoing assessment with the Medicines and Healthcare products Regulatory Agency for a marketing authorisation in the UK
Cancer clinical trial recruitment drops by 60% during pandemic
In a new report from The Institute of Cancer Research (ICR), data from cancer trials alongside assessments from clinicians and patients aims to provide guidance on how to improve services
Marketing authorisation acquired for first and only transdermal contraceptive patch in UK
The Evra hormonal patch can be worn discreetly and according to Gedeon Richter UK Ltd, is over 99% effective at pregnancy prevention
WHO says vaccines should be effective against Omicron variant
A senior official at the World Health Organisation (WHO) has said that Omicron is ‘highly unlikely’ to fully bypass vaccine protections.
UK study shows mixing Pfizer and AstraZeneca COVID-19 vaccines with Moderna elicits better immune response
Results show support in favour of heterologous dosing which may help to advance vaccination programmes in poorer countries.
CHMP recommend approval for Roche’s COVID-19 therapy
According to clinical data, Roche’s new COVID-19 treatment Actemra/RoActemra lowered mortality risk in critically ill adult patients.
GPs in England to defer services to accelerate booster jab delivery
GP practices can now postpone minor surgery and routine health checks for over-75s and new patients until 31 March 2022 to ensure booster jabs are rapidly and effectively delivered.
Next virus could be more lethal than COVID-19, warns Oxford vaccine creator
With the emergence of the new Omicron variant bringing into question the effectiveness of current vaccines, scientists caution that viruses will continue to evolve.
GSK to provide malaria vaccines for Gavi eligible countries
The new development will arm healthcare providers with a vital tool to address the steep rise of malaria cases in children living in Africa.
NIHR study shows high efficacy of booster vaccines
The news arrives after the tenth recorded positive Omicron case in Scotland, which the government has confirmed has no previous connection to the previous nine.
UK orders extra 114 million COVID-19 vaccines to combat Omicron
Scientists and health experts have cautioned that the new variant could have the ability to bypass the effectiveness of vaccines that are currently available.
Possible identification of blood clot trigger for AstraZeneca COVID-19 vaccine
Researchers have identified in those patients experiencing blood clots after vaccination a subsequent condition referred to as vaccine-induced immune thrombotic thrombocytopenia (VITT).
